Rodec Pharma Ltd Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs |

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Rodec Pharma

Based on:

DeciZen not available for IPO

10 Year X-Ray of Rodec Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'23Mar'24Mar'25TTM
ROCE % 23.6%44.9%53.2%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 71.688.41060
Sales YoY Gr.-23.5%20.3%-
Adj EPS 2.34.98.10
YoY Gr.-110.8%65.7%-
BVPS (₹) 9.11422.10
Adj Net
Profit
5.21118.2NAN
Cash Flow from Ops. 10.698.9-
Debt/CF from Ops. 1.10.70.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA20.3%
Adj EPS NANANA65.7%
BVPSNANANA57.6%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'23Mar'24Mar'25TTM
Return on
Equity %
25.24244.60
Op. Profit
Mgn %
11.417.824.3NAN
Net Profit
Mgn %
7.312.417.1NAN
Debt to
Equity
0.60.20.2-
Working Cap
Days
01251500
Cash Conv.
Cycle
030510

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Rodec Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray of Rodec Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Rodec Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Rodec Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25
Sales71.6188.42106.39
Operating Expenses 63.4772.6680.58
Manufacturing Costs0.371.251.47
Material Costs29.2529.1331.24
Employee Cost 17.5020.2125.63
Other Costs 16.3522.0722.24
Operating Profit 8.1515.7725.81
Operating Profit Margin (%) 11.4%17.8%24.3%
Other Income 0.111.191.80
Interest 0.540.800.81
Depreciation 0.601.201.89
Exceptional Items 000
Profit Before Tax 7.1215.1224.91
Tax 1.914.086.65
Profit After Tax 5.2111.0418.26
PAT Margin (%) 7.3%12.5%17.2%
Adjusted EPS (₹)2.34.98.1
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 20.6731.7550.04
Share Capital 0.100.100.10
Reserves 20.5631.6549.93
Minority Interest000
Debt11.396.357.87
Long Term Debt4.912.212.33
Short Term Debt6.484.145.54
Trade Payables5.085.315.60
Others Liabilities 6.566.677.80
Total Liabilities 43.7050.0871.30

Fixed Assets

Gross Block12.7713.2320.20
Accumulated Depreciation2.022.714.19
Net Fixed Assets 10.7510.5216.01
CWIP 2.404.900
Investments 2.571.131.13
Inventories3.084.616.86
Trade Receivables9.0211.8122.12
Cash Equivalents 1.030.060.08
Others Assets 14.8417.0525.09
Total Assets 43.7050.0871.30

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25
Cash Flow From Operating Activity 10.619.028.86
PBT 7.1215.1224.91
Adjustment 0.970.640.86
Changes in Working Capital 4.16-3.49-10.57
Tax Paid -1.64-3.25-6.34
Cash Flow From Investing Activity -14.25-6.42-8.19
Capex -5.38-3.42-2.43
Net Investments -2.571.600
Others -6.30-4.59-5.76
Cash Flow From Financing Activity 3.28-3.47-0.65
Net Proceeds from Shares 000
Net Proceeds from Borrowing 3.79-2.700.12
Interest Paid -0.51-0.77-0.76
Dividend Paid 000
Others 000
Net Cash Flow -0.37-0.860.02

Finance Ratio

PARTICULARSMar'23Mar'24Mar'25
Ratios
ROE (%)25.2142.1144.65
ROCE (%)23.6444.9453.17
Asset Turnover Ratio1.641.891.75
PAT to CFO Conversion(x)2.040.820.49
Working Capital Days
Receivable Days464358
Inventory Days161620
Payable Days636564

Rodec Pharma Ltd Stock News

Rodec Pharma Ltd FAQs

The current trading price of Rodec Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Rodec Pharma stood at ₹0.00.
The latest P/E ratio of Rodec Pharma as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Rodec Pharma as of 31-Dec-1969 is 0.00.
The 52-week high of Rodec Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rodec Pharma is ₹0.00 ( Cr.) .

About Rodec Pharma Ltd

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×